OSTK continues to eat market share from W and P/S should approach 2. This is w/o accounting for the Medici Ventures portfolio providing a potentially large real option at no (close to 0) further cost.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
